UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2003 MANHATTAN SCIENTIFICS, INC (Exact name of Registrant as specified in charter) DELAWARE 0-28411 85-0460639 (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation) Identification Number) 641 FIFTH AVENUE, SUITE 36F NEW YORK, NY 10022 (Address of principal executive offices) Registrant's telephone number, including area code: (212) 752-0505 NOT APPLICABLE (Former name or former address, if changed since last report) ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE. SEE ATTACHED PRESS RELEASE AND LETTER TO SHAREHOLDERS ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (A) FINANCIAL STATEMENTS OF BUSINESSES ACQUIRED. Not applicable. (B) PRO FORMA FINANCIAL INFORMATION Not applicable. (C) EXHIBITS Exh. No. Description -------- ------------ 99.1 Press Release dated May 9, 2003 99.2 Letter to Stockholders dated May 9, 2003 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 9, 2003 MANHATTAN SCIENTIFICS, INC. By: /S/ MARVIN MASLOW ----------------------- Marvin Maslow Chief Executive Officer 3 EXHIBITS FILED WITH THIS REPORT Exh. No. Description - -------- ----------- 99.1 Press Release dated May 9, 2003. 99.2 Letter to Stockholders dated May 9, 2003 4